Carlsmed, Inc. Investment Income, Interest
Carlsmed, Inc. (CARL) reported Investment Income, Interest of $839.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-05
- Carlsmed, Inc. investment income, interest for the quarter ending 2026-06-30 was $839.00K, a 149.70% increase year-over-year.
- Carlsmed, Inc. investment income, interest for the quarter ending 2026-03-31 was $891.00K, a 134.47% increase year-over-year.
- Carlsmed, Inc. investment income, interest for the quarter ending 2025-12-31 was $1.03M, a 150.73% increase year-over-year.
- Carlsmed, Inc. investment income, interest for the quarter ending 2025-09-30 was $954.00K, a 142.13% increase year-over-year.
- Carlsmed, Inc. investment income, interest for fiscal 2025 was $2.70M, a 102.86% increase from fiscal 2024.
- Carlsmed, Inc. investment income, interest for fiscal 2024 was $1.33M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $839.00K 10-Q · filed 2026-08-05 | $1.73M 10-Q · filed 2026-08-05 | $2.76M derived: sum of 3 quarters · filed 2026-08-05 | $3.71M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $891.00K 10-Q · filed 2026-05-05 | $1.92M derived: sum of 2 quarters · filed 2026-05-05 | $2.87M derived: sum of 3 quarters · filed 2026-05-05 | $3.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.98M derived: sum of 2 quarters · filed 2026-02-25 | $2.32M derived: sum of 3 quarters · filed 2026-08-05 | $2.70M 10-K · filed 2026-02-25 |
| 2025-09-30 | $954.00K 10-Q · filed 2025-11-06 | $1.29M derived: sum of 2 quarters · filed 2026-08-05 | $1.67M 10-Q · filed 2025-11-06 | $2.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $336.00K 10-Q · filed 2026-08-05 | $716.00K 10-Q · filed 2026-08-05 | $1.13M derived: sum of 3 quarters · filed 2026-08-05 | $1.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $380.00K 10-Q · filed 2026-05-05 | $790.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.18M derived: sum of 3 quarters · filed 2026-05-05 | $1.61M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $804.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.23M derived: sum of 3 quarters · filed 2026-02-25 | $1.33M 10-K · filed 2026-02-25 |
| 2024-09-30 | $394.00K 10-Q · filed 2025-11-06 | $822.00K derived: sum of 2 quarters · filed 2025-11-06 | $920.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $428.00K 10-Q · filed 2025-08-28 | $526.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |